SetPoint Medical is pioneering bioelectronic medicine therapies to treat autoimmune diseases such as rheumatoid arthritis, Crohn's Disease, and multiple sclerosis. The company has developed a proprietary bioelectronic medicine platform consisting of a micro-regulator programmed via a unique prescription pad-based interface, offering a safe and efficacious alternative to drugs.

SetPoint Medical

SetPoint Medical is developing novel bioelectronic medicine therapies to treat those who suffer from autoimmune diseases such as rheumatoid arthritis, Crohn's Disease and multiple sclerosis.  The company has developed a proprietary and innovative bioelectronic medicine platform consisting of a micro-regulator programmed via a unique prescription pad based interface.  This novel therapy has the potential to provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payers significantly less than  biologic therapies.

Runway Growth Capital

Action Potential Venture Capital

Euclidean Capital

Boston Scientific

Citta Capital

New Enterprise Associates

Gilmartin Capital LLC

SVE Capital

Richard King Mellon Foundation

Shangbay Capital

CITA Investissement

Midas Capital

Morgenthaler Ventures

Topspin Fund

Revelation Partners

This holiday season, we want to take a moment to extend our gratitude to all the SetPoint employees who worked so hard to make this year special. Your passion and dedication to developing this novel therapy to help RA patients is deeply inspiring! We celebrated this year’s numerous achievements with some great food and holiday cheer.

Wishing each of you and your loved ones a holiday season brimming with joy, peace, and good health.

This #Thanksgiving, we want to extend our profound gratitude to all the incredible people who make the RESET-RA study possible. We deeply appreciate the dedication and hard work of our partners, investigators, and staff. And to our RA study participants, your resilience and strength are truly inspiring. You are appreciated immensely! We look forward to our continued collaboration with you as we evaluate the therapeutic potential of this technology. Wishing our entire community a warm and joyful Thanksgiving!

🧟‍♀️ 🧛‍♂️ #HappyHalloween2023 🧛‍♀️ 🧟‍♂️ 

Each year, we are amazed at the ingenuity and creativity of our team!

#TheSetPointAdvantage

msh id	COM:SETPOINTMEDICAL
symbol	-
name	SetPoint Medical
homepage url	https://setpointmedical.com
country	US
sector	Healthcare
industry	Medical Equipment Manufacturing
market	PRIVATE
employee count	81
crunchbase url	https://www.crunchbase.com/organization/setpoint-medical
linkedin url	https://www.linkedin.com/company/setpoint-medical
founders	-

market cap	114.61M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	250
monthly webtraffic growth	1.4
growth score 14	53.3
growth score 28	57.92
growth score 90	59.21
growth score 365	72.48

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

COM:SETPOINTMEDICAL

SetPoint Medical

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-